Poulton Jeffrey V.

EDGAR CIK 0001782962

Alnylam Pharmaceuticals, Inc. - ALNY

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
EVP, Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
6
($5.98) M
-15,791 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/04/2026
03/06/2026
Sell
-2,468 @ $323.08
 ($797,351) 61,805 (-3.84%) Direct
03/02/2026
03/04/2026
Sell
-2,206 @ $327.65
 ($722,801) 64,273 (-3.32%) Direct
02/13/2026
02/17/2026
Sell
-2,242 @ $310.08
 ($695,201) 59,802 (-3.61%) Direct
01/12/2026
01/14/2026
Sell
-2,780 @ $362.87
 ($1,008,766) 57,465 (-4.61%) Direct
10/02/2025
10/03/2025
Sell
-3,821 @ $452.05
 ($1,727,284) 54,052 (-6.60%) Direct
08/18/2025
08/19/2025
Sell
-2,274 @ $453.27
 ($1,030,727) 50,121 (-4.34%) Direct